Acetazolamide

Overview

4.6 out of 5 (157 Reviews)

Credits

1.50

Post Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Acetazolamide is a diuretic and carbonic anhydrase inhibitor medication used to treat several illnesses. It works to cause an accumulation of carbonic acid by preventing its breakdown. FDA-approved indications include glaucoma, idiopathic intracranial hypertension, congestive heart failure, altitude sickness, periodic paralysis, and epilepsy. In addition, it is used off-label for central sleep apnea, Marfan syndrome, prevention of high-dose methotrexate nephrotoxicity, and prevention of contrast-induced nephropathy. This activity outlines the indications, contraindications, interactions, monitoring, and other therapeutic information pertinent to members of an interprofessional team in the care of patients with conditions requiring the use of acetazolamide.

UAN: JA4008338-0000-23-212-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the indications for acetazolamide, both FDA-approved and off-label.
  • Describe the mechanism of action of acetazolamide.
  • Summarize the adverse event profile of acetazolamide.
  • Explain the importance of collaboration and coordination among the interprofessional team and how it can enhance patient care with acetazolamide therapy to improve patient outcomes for patients with indicated conditions.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.50 ACPE credit(s). (UAN: JA4008338-0000-23-212-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Sandra S. on 1/7/2021

Deborah Z. on 1/10/2021

I am just thankful that STATPEARLS has over 100 education activities specific to ophthalmology!

Ramonia W. on 4/6/2021

Sandeep S. on 5/9/2021

Crystal B. on 8/6/2021

CASSANDRA F. on 8/13/2021

cynthia o. on 8/20/2021

Alana H. on 8/23/2021

Mary S. on 9/3/2021

Marquita M. on 9/6/2021

Roshni J. on 9/18/2021

Anundip G. on 9/21/2021

Harry A. on 9/26/2021

Erika A. on 9/30/2021

Hurline S. on 10/5/2021

IJAZ V. on 10/10/2021

Patrick G. on 10/14/2021

Claire H. on 10/15/2021

Mirta A. on 10/17/2021

Kathleen D. on 10/31/2021

Rodolfo S. on 12/19/2021

amanda b. on 12/12/2021

Tiffany M. on 12/18/2021

Valerie F. on 12/28/2021

Terri C. on 1/4/2022

John S. on 1/4/2022

Karen R. on 1/16/2022

Christina R. on 2/8/2022

Prabhakar g. on 2/10/2022

Frederick a. on 2/26/2022

devin n. on 2/26/2022

Kathy W. on 3/17/2022

Jillian K. on 4/18/2022

IJAZ V. on 5/8/2022

Ejaz J. on 5/28/2022

Stephen A. on 6/1/2022

Rodabeh M. on 6/5/2022

Stephanie C. on 6/5/2022

on 6/23/2022

Nancy F. on 6/25/2022

John P. on 6/30/2022

Jennifer L. on 7/6/2022

Melissa B. on 7/16/2022

Susan G. on 8/25/2022

Mark R. on 9/26/2022

Elizabeth M. on 9/30/2022

Daniel S. on 9/30/2022

Maylin G. on 10/10/2022

Ivonne D. on 10/15/2022

Kevin M. on 10/24/2022

Charles W. on 11/13/2022

Rayne R. on 11/21/2022

Janice R. on 12/6/2022

long h. on 12/8/2022

Li Mei L. on 12/11/2022

Allison A. on 12/20/2022

albert n. on 12/23/2022

Brian C. on 12/22/2022

Rita M. on 12/28/2022

Natalie p. on 1/4/2023

Dakota P. on 1/4/2023

Stephanie C. on 1/26/2023

Stephanie F. on 2/3/2023

hassan g. on 2/10/2023

Florence Y. on 2/18/2023

Bashiru B. on 2/25/2023

Jorge M. on 2/28/2023

Rose F. on 2/28/2023

John C. on 3/1/2023

Cruz s. on 3/3/2023

Joanne S. on 3/13/2023

Brittany W. on 3/28/2023

Murali M. on 3/25/2023

Samantha C. on 3/26/2023

Alexander D. on 3/27/2023

Michael V. on 3/30/2023

Michael A. on 8/26/2022

yvette t. on 8/12/2022

Josh P. on 4/4/2023

Divya J. on 4/19/2023

Jane C. on 4/23/2023

Brittany P. on 4/23/2023

Austin T. on 5/1/2023

Valerie B. on 5/5/2023

Mohammed J. on 5/14/2023

Jana T. on 5/17/2023

Mary M. on 5/22/2023

Heather D. on 5/24/2023

Christina R. on 5/30/2023

Deanna M. on 6/7/2023

Daniel K. on 6/7/2023

Rakesh M. on 6/8/2023

Amber S. on 6/13/2023

CASSANDRA F. on 6/14/2023

Tara B. on 6/27/2023

Dennis R. on 7/15/2023

Natasha M. on 8/15/2023

shahid i. on 8/19/2023

Allynda H. on 8/20/2023

Nicholas T. on 8/24/2023

Vera F. on 8/23/2023

Mary C. on 9/3/2023

Ali S. on 10/30/2023

Syeda A. on 9/5/2023

Genevieve M. on 9/17/2023

Jonathan Z. on 9/18/2023

Stephanie R. on 9/25/2023

Melissa B. on 9/29/2023

Timothy R. on 10/2/2023

Preman S. on 10/5/2023

Guy N. on 10/9/2023

THIRUMALESH V. on 10/16/2023

Ralph C. on 10/17/2023

Jami P. on 10/19/2023

Vu H. on 10/19/2023

Brian G. on 10/20/2023

John M. on 10/20/2023

DELALI A. on 10/20/2023

Sydney w. on 10/23/2023

MICHELLE B. on 10/24/2023

Nyomi W. on 10/26/2023

Jordan L. on 10/27/2023

Shivan K. on 10/27/2023

Faith M. on 12/12/2023

Denise W. on 11/1/2023

Sailatha B. on 11/1/2023

Kathryn T. on 11/8/2023

Chad S. on 11/11/2023

Elisabeth I. on 11/14/2023

Andrew C. on 11/15/2023

Edward F. on 11/16/2023

ISLAM A. on 11/19/2023

Brian M. on 11/21/2023

ravinder w. on 11/23/2023

Paige C. on 12/14/2023

Jakob H. on 12/17/2023

Elizabeth B. on 12/29/2023

Mary Y. on 1/5/2024

Ali I. on 1/6/2024

Stacey S. on 1/11/2024

Monique A. on 2/1/2024

Therese M. on 2/3/2024

Natasha D. on 2/29/2024

Yashma P. on 3/9/2024

Peter L. on 3/25/2024

JEANNETTE A. on 3/24/2024

Excellent

Khodaidad B. on 4/2/2024

Kate J. on 4/21/2024

Natalie F. on 5/19/2024

Elizabeth F. on 5/21/2024

Glenn F. on 6/10/2024

Hilina y. on 6/20/2024

Milejah H. on 6/30/2024

Jaclyn B. on 7/2/2024

Alan y. on 7/9/2024

Jobet R. on 7/22/2024

Andrea L. on 7/22/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user